Anna Kamlárová

Probiotic drug interactions in ulcerative colitis: a microbiota and metabolite perspective

Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease that imposes a substantial lifelong burden on patients, particularly as it commonly develops during adolescence or early adulthood. Despite major advances in pharmacological management, including the introduction of biologic agents and small-mole...